IBB
ETF
Biotechnology
NASDAQ
iShares Biotechnology ETF
$203.72
-1.67 (-0.81%)
Fund Overview
by iShares (BlackRock)
Tracks the Nasdaq Biotechnology Index with market-cap weighting. Large-cap biotech dominance from Amgen, Gilead, Regeneron, and Vertex, with a long tail of smaller clinical-stage companies.
AUM$7.8B
Expense Ratio0.44%
Holdings224
Dividend Yield0.2%
DistributionQuarterly
BenchmarkNasdaq Biotechnology Index
InceptionFeb 2001
ExchangeNASDAQ
Price Data
Open$205.75
Prev Close$205.39
Day Range$203.29 — $208.04
52W Range$107.43 — $179.64
52-Week Range
$107.43
$179.64
From 52W High
13.4%
From 52W Low
+89.6%
Investment Calculator
See how much dividend income IBB could generate based on its current price of $203.72 and 0.2% yield. Adjust the amount to estimate your quarterly distributions.
$
Shares Purchased
Amount Invested$9,982.28
Annual Income$19.96
Monthly Income$1.66
Based on current dividend yield of 0.2%. Actual distributions may vary. Past dividends do not guarantee future payments.
Biotechnology ETF Comparison
Top Biotechnology Stocks
View all →
| Stock | Price | Change | Market Cap |
|---|---|---|---|
| ABBV | $283.54 | -0.86% | 520.47B |
| AMGN | $438.82 | -1.14% | 252.64B |
| GILD | $166.53 | -1.45% | 208.95B |
| VRTX | $520.66 | -2.94% | 134.82B |
| REGN | $923.34 | -2.35% | 98.38B |
| MRNA | $199.33 | +1.29% | 90.54B |
| NTRA | $289.92 | +0.15% | 45.90B |
| RVMD | $159.43 | -0.24% | 37.37B |
| BIIB | $247.13 | -1.70% | 37.21B |
| ROIV | $38.96 | +0.59% | 28.64B |
IBB FAQ
What is IBB?
IBB is the iShares Biotechnology ETF, an exchange-traded fund managed by iShares (BlackRock). It tracks the Nasdaq Biotechnology Index and holds 224 Biotechnology securities with an expense ratio of 0.44%.
What is the expense ratio of IBB?
IBB charges an annual expense ratio of 0.44%, which means you pay $44.00 per year for every $10,000 invested. This fee is deducted automatically from the fund's returns.
Does IBB pay dividends?
Yes, IBB pays a 0.2% dividend yield, distributed quarterly. On a $10,000 investment, that works out to approximately $20.00 per year in dividend income.
Explore Biotechnology Stocks
View our full list of individual biotechnology stocks with prices, fundamentals, and analyst ratings.
Last updated: Nov 19, 2026 at 10:42 PM ET